Evidence map›Paper›PMID 32902203›Full record

ArticleCancer reports (Hoboken, N.J.)2020

Recurrent genetic abnormalities detected by FISH in adult B ALL and association with hematological parameters.

Anil Tarigopula, Vani Chandrashekar, Govindasami Perumal

Open access · bronzeAbstract read
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anil TarigopulaDepartment of Centralised Molecular Diagnostics, Apollo Hospitals, Chennai, Tamil Nadu, India.
Vani ChandrashekarDepartment of Hematology, Apollo Hospitals, Chennai, Tamil Nadu, India.ORCID 0000-0003-0092-1486
Govindasami PerumalDepartment of Centralised Molecular Diagnostics, Apollo Hospitals, Chennai, Tamil Nadu, India.
Apollo Hospitals · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecurrent genetic abnormalities influence prognosis in B lymphoblastic leukemia. BCR-ABL rearrangement is associated with higher leukocyte counts and older age at presentation. Among adults, BCR -ABL - is the commonest recurrent abnormality whereas, IgH rearrangements are rare.

aimAim of this study was to identify common recurrent genetic abnormalities in adult B ALL and study their association with hematological findings.

methodsBone marrow and peripheral blood from patients with B acute lymphoblastic leukemia were analyzed for complete blood counts, bone marrow morphology and cytogenetic abnormalities. The study group was divided into smaller groups based on cytogenetic abnormalities. Hematological parameters and presence of recurrent genetic abnormalities was compared across age groups and gender by non parametric tests.

resultsBCR-ABL positive group had a higher leukocyte count than BCR-ABL negative group. Among groups 1 to 5, group 1 with gains of chromosomes was associated with leucopenia and higher age at presentation. BCR-ABL is commonest recurrent abnormality followed by IgH rearrangements.

conclusionPatients with gains of chromosomes alone have low total leukocyte counts at presentation.

Indexed as

Chromosome AberrationsAdolescentAdultAgedFemaleFusion Proteins, bcr-ablGene RearrangementHumansImmunoglobulin Heavy ChainsIn Situ Hybridization, FluorescenceMaleMiddle AgedPrecursor B-Cell Lymphoblastic Leukemia-LymphomaYoung AdultFusion Proteins, bcr-ablImmunoglobulin Heavy ChainsB acute lymphoblastic leukemiaBCR-ABLIgH rearrangementMLLMYCTCF3/PBX

Identifiers

PMID32902203
PMCPMC7941533
OpenAlexW3086770207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.